Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Favreau

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Biomedical Optics|October 30, 2016
Hyperspectral imaging fluorescence excitation scanning for colon cancer detectionSilas J Leavesley, Mikayla Walters, Carmen Lopez, et al.
Proceedings of Spie--The International Society for Optical Engineering|August 25, 2021
Hyperspectral Imaging Fluorescence Excitation Scanning for Detecting Colorectal Cancer: Pilot StudySilas J Leavesley, Mikayla Wheeler, Carmen Lopez, et al.
Journal of Tissue Engineering|February 16, 2024
Human induced pluripotent stem cell-derived planar neural organoids assembled on synthetic hydrogelsJoydeb Majumder, Elizabeth E Torr, Elizabeth A Aisenbrey, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 9, 2020
A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activationSheena C Kerr, Molly M Morgan, Amani A Gillette, et al.
Molecular Cancer Therapeutics|November 15, 2018
MTORC1/2 Inhibition as a Therapeutic Strategy for <i>PIK3CA</i> Mutant CancersStephanie L Fricke, Susan N Payne, Peter F Favreau, et al.
Molecular Cancer Therapeutics|July 10, 2025
BCL-2 family inhibition enhances MTORC1/2 inhibition in PIK3CA mutant colorectal cancerRebecca A DeStefanis, Alexa E Schmitz, Alyssa K Steimle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and RadiationCheri A Pasch, Peter F Favreau, Alexander E Yueh, et al.
Scientific Reports|April 8, 2025
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivityJeremy D Kratz, Shujah Rehman, Katherine A Johnson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Biomedical Optics|October 30, 2016
Hyperspectral imaging fluorescence excitation scanning for colon cancer detectionSilas J Leavesley, Mikayla Walters, Carmen Lopez, et al.
Proceedings of Spie--The International Society for Optical Engineering|August 25, 2021
Hyperspectral Imaging Fluorescence Excitation Scanning for Detecting Colorectal Cancer: Pilot StudySilas J Leavesley, Mikayla Wheeler, Carmen Lopez, et al.
Journal of Tissue Engineering|February 16, 2024
Human induced pluripotent stem cell-derived planar neural organoids assembled on synthetic hydrogelsJoydeb Majumder, Elizabeth E Torr, Elizabeth A Aisenbrey, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 9, 2020
A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activationSheena C Kerr, Molly M Morgan, Amani A Gillette, et al.
Molecular Cancer Therapeutics|November 15, 2018
MTORC1/2 Inhibition as a Therapeutic Strategy for <i>PIK3CA</i> Mutant CancersStephanie L Fricke, Susan N Payne, Peter F Favreau, et al.
Molecular Cancer Therapeutics|July 10, 2025
BCL-2 family inhibition enhances MTORC1/2 inhibition in PIK3CA mutant colorectal cancerRebecca A DeStefanis, Alexa E Schmitz, Alyssa K Steimle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and RadiationCheri A Pasch, Peter F Favreau, Alexander E Yueh, et al.
Scientific Reports|April 8, 2025
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivityJeremy D Kratz, Shujah Rehman, Katherine A Johnson, et al.
Pageof 2